Biotech in Balance

Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust is a timely and provocative examination of the biotechnology industry from one of its most experienced insiders, Dr. Jeremy M. Levin. Drawing on decades as a physician, scientist, and pharmaceutical executive, Levin explores how politics, public distrust, rising drug costs, and global competition are reshaping the future of medicine and healthcare innovation. He argues that biotechnology is not simply an industry, but a strategic national asset critical to public health, economic security, and scientific progress.

‍

At the center of the book is a call to restore trust between science, industry, government, and the public. Levin examines how opaque pricing systems, supply-chain vulnerabilities, and financial incentives have weakened confidence in healthcare while driving up costs for patients. Combining personal experience with practical reforms, Biotech in the Balance presents a roadmap for strengthening biotechnology, protecting American innovation, and ensuring that lifesaving medicines remain accessible in an increasingly uncertain world.

‍